An in-depth look to ELICERA THERAPEUTICS AB operating, investing, and financing activities

ELIC free cash flow for Q2 24 is -7.73 M SEK. For 2023, ELIC free cash flow was -14.92 M SEK and operating cash flow was -14.92 M SEK.